BiotechTube
Home/Aurigene Pharmaceutical Services/Dr. Gopal Reddy
DG

Dr. Gopal Reddy

CEO

Aurigene Pharmaceutical Services

Therapeutic Areas

OncologyImmunology

Aurigene Pharmaceutical Services Pipeline

DrugIndicationPhase
AUR-101Triple‑negative breast cancer and solid tumorsPreclinical
AUR-102MYC‑driven cancersPreclinical
AUR-103B‑cell malignanciesPreclinical

Leadership Team at Aurigene Pharmaceutical Services

DA
Dr. Ananya Sharma
CSO
View full Aurigene Pharmaceutical Services profile